Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
SZGIMI
Welcome,
Profile
Billing
Logout
Products
Diseases
Products
Trials
News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
4SCAR-T
/ SZGIMI
4SCAR-276
/ SZGIMI
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
/ SZGIMI
4SCAR-CD44v6 T Cell Therapy
/ SZGIMI
4SCAR-PSMA T cells
/ SZGIMI
CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells
/ SZGIMI
Covid-19 aAPC Vaccine
/ SZGIMI
GD2, PSMA and CD276 CAR-T
/ SZGIMI
LV-DC vaccine
/ SZGIMI
Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells
/ SZGIMI
YUVA-GT-F801
/ SZGIMI
YUVA-GT-F901
/ SZGIMI
bi-4SCAR CD19/22 T
/ SZGIMI
bi-4SCAR CD19/70
/ SZGIMI
bi-4SCAR CD19/79b
/ SZGIMI
bi-4SCAR GD2/CD56
/ SZGIMI
bi-4SCAR GD2/CD70
/ SZGIMI
bi-4SCAR GD2/PSMA
/ SZGIMI
bi-4SCAR PSMA/CD70
/ SZGIMI
multi-CAR-T cell therapy
/ SZGIMI
